PortalPublikationenExcess costs from functional somatic syndromes in Germany - ...

Excess costs from functional somatic syndromes in Germany - An analysis using entropy balancing

Standard

Excess costs from functional somatic syndromes in Germany - An analysis using entropy balancing. / Grupp, Helen; Kaufmann, Claudia; König, Hans-Helmut; Bleibler, Florian; Wild, Beate; Szecsenyi, Joachim; Herzog, Wolfgang; Schellberg, Dieter; Schäfert, Rainer; Konnopka, Alexander.

in: J PSYCHOSOM RES, Jahrgang 97, 06.2017, S. 52-57.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Grupp, H, Kaufmann, C, König, H-H, Bleibler, F, Wild, B, Szecsenyi, J, Herzog, W, Schellberg, D, Schäfert, R & Konnopka, A 2017, 'Excess costs from functional somatic syndromes in Germany - An analysis using entropy balancing', J PSYCHOSOM RES, Jg. 97, S. 52-57. https://doi.org/10.1016/j.jpsychores.2017.04.002

APA

Grupp, H., Kaufmann, C., König, H-H., Bleibler, F., Wild, B., Szecsenyi, J., Herzog, W., Schellberg, D., Schäfert, R., & Konnopka, A. (2017). Excess costs from functional somatic syndromes in Germany - An analysis using entropy balancing. J PSYCHOSOM RES, 97, 52-57. https://doi.org/10.1016/j.jpsychores.2017.04.002

Vancouver

Grupp H, Kaufmann C, König H-H, Bleibler F, Wild B, Szecsenyi J et al. Excess costs from functional somatic syndromes in Germany - An analysis using entropy balancing. J PSYCHOSOM RES. 2017 Jun;97:52-57. https://doi.org/10.1016/j.jpsychores.2017.04.002

Bibtex

@article{7a08f6eddaf74415a3ebd2c11bb12948,
title = "Excess costs from functional somatic syndromes in Germany - An analysis using entropy balancing",
abstract = "AIM: The aim of this study was to calculate disorder-specific excess costs in patients with functional somatic syndromes (FSS).METHODS: We compared 6-month direct and indirect costs in a patient group with FSS (n=273) to a control group of the general adult population in Germany without FSS (n=2914). Data on the patient group were collected between 2007 and 2009 in a randomized controlled trial (speciAL). Data on the control group were obtained from a telephone survey, representative for the general German population, conducted in 2014. Covariate balance between the patient group and the control group was achieved using entropy balancing. Excess costs were calculated by estimating generalized linear models and two-part models for direct costs and indirect costs. Further, we estimated excess costs according to the level of somatic symptom severity (SSS).RESULTS: FSS patients differed significantly from the control group regarding 6-month costs of outpatient physicians (+€280) and other outpatient providers (+€74). According to SSS, significantly higher outpatient physician costs were found for mild (+€151), moderate (+€306) and severe (+€376) SSS. We also found significantly higher costs of other outpatient providers in patients with mild, moderate and severe SSS. Regarding costs of rehabilitation and hospital treatments, FSS patients did not differ significantly from the control group for any level of SSS. Indirect costs were significantly higher in patients with severe SSS (+€760).CONCLUSION: FSS were of major importance in the outpatient sector. Further, we found significantly higher indirect costs in patients with severe SSS.",
keywords = "Journal Article",
author = "Helen Grupp and Claudia Kaufmann and Hans-Helmut K{\"o}nig and Florian Bleibler and Beate Wild and Joachim Szecsenyi and Wolfgang Herzog and Dieter Schellberg and Rainer Sch{\"a}fert and Alexander Konnopka",
note = "Copyright {\textcopyright} 2017 Elsevier Inc. All rights reserved.",
year = "2017",
month = jun,
doi = "10.1016/j.jpsychores.2017.04.002",
language = "English",
volume = "97",
pages = "52--57",
journal = "J PSYCHOSOM RES",
issn = "0022-3999",
publisher = "Elsevier Inc.",

}

RIS

TY - JOUR

T1 - Excess costs from functional somatic syndromes in Germany - An analysis using entropy balancing

AU - Grupp, Helen

AU - Kaufmann, Claudia

AU - König, Hans-Helmut

AU - Bleibler, Florian

AU - Wild, Beate

AU - Szecsenyi, Joachim

AU - Herzog, Wolfgang

AU - Schellberg, Dieter

AU - Schäfert, Rainer

AU - Konnopka, Alexander

N1 - Copyright © 2017 Elsevier Inc. All rights reserved.

PY - 2017/6

Y1 - 2017/6

N2 - AIM: The aim of this study was to calculate disorder-specific excess costs in patients with functional somatic syndromes (FSS).METHODS: We compared 6-month direct and indirect costs in a patient group with FSS (n=273) to a control group of the general adult population in Germany without FSS (n=2914). Data on the patient group were collected between 2007 and 2009 in a randomized controlled trial (speciAL). Data on the control group were obtained from a telephone survey, representative for the general German population, conducted in 2014. Covariate balance between the patient group and the control group was achieved using entropy balancing. Excess costs were calculated by estimating generalized linear models and two-part models for direct costs and indirect costs. Further, we estimated excess costs according to the level of somatic symptom severity (SSS).RESULTS: FSS patients differed significantly from the control group regarding 6-month costs of outpatient physicians (+€280) and other outpatient providers (+€74). According to SSS, significantly higher outpatient physician costs were found for mild (+€151), moderate (+€306) and severe (+€376) SSS. We also found significantly higher costs of other outpatient providers in patients with mild, moderate and severe SSS. Regarding costs of rehabilitation and hospital treatments, FSS patients did not differ significantly from the control group for any level of SSS. Indirect costs were significantly higher in patients with severe SSS (+€760).CONCLUSION: FSS were of major importance in the outpatient sector. Further, we found significantly higher indirect costs in patients with severe SSS.

AB - AIM: The aim of this study was to calculate disorder-specific excess costs in patients with functional somatic syndromes (FSS).METHODS: We compared 6-month direct and indirect costs in a patient group with FSS (n=273) to a control group of the general adult population in Germany without FSS (n=2914). Data on the patient group were collected between 2007 and 2009 in a randomized controlled trial (speciAL). Data on the control group were obtained from a telephone survey, representative for the general German population, conducted in 2014. Covariate balance between the patient group and the control group was achieved using entropy balancing. Excess costs were calculated by estimating generalized linear models and two-part models for direct costs and indirect costs. Further, we estimated excess costs according to the level of somatic symptom severity (SSS).RESULTS: FSS patients differed significantly from the control group regarding 6-month costs of outpatient physicians (+€280) and other outpatient providers (+€74). According to SSS, significantly higher outpatient physician costs were found for mild (+€151), moderate (+€306) and severe (+€376) SSS. We also found significantly higher costs of other outpatient providers in patients with mild, moderate and severe SSS. Regarding costs of rehabilitation and hospital treatments, FSS patients did not differ significantly from the control group for any level of SSS. Indirect costs were significantly higher in patients with severe SSS (+€760).CONCLUSION: FSS were of major importance in the outpatient sector. Further, we found significantly higher indirect costs in patients with severe SSS.

KW - Journal Article

U2 - 10.1016/j.jpsychores.2017.04.002

DO - 10.1016/j.jpsychores.2017.04.002

M3 - SCORING: Journal article

C2 - 28606499

VL - 97

SP - 52

EP - 57

JO - J PSYCHOSOM RES

JF - J PSYCHOSOM RES

SN - 0022-3999

ER -